GL1X · GenesisL1 explorer

Research workbench

Crystal structure of inhibitor jnj-49153390 in complex with prefusion rsv F glycoprotein

Analyse Crystal structure of inhibitor jnj-49153390 in complex with prefusion rsv F… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5EA4
Type
protein
Length
443 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fusion glycoprotein F0
UniProt
P03420
Ligands
5NM, SO4
Pockets
3 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
FFusion glycoprotein F0protein44330% helix, 34% strandP03420

Ligands and binding sites

  • 5NM · 3-[[5-bromanyl-1-(3-methylsulfonylpropyl)benzimidazol-2-yl]methyl]-1-cyclopropyl-imidazo[4,5-c]pyridin-2-one · ligand · chains F
  • SO4 · Sulfate ion · ion · 5 copies · chains F
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.370.8014empty
2610.280.7415empty
3530.270.7412empty

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 5EA4 · Crystal Structure of Inhibitor JNJ-49153390 in Complex with Prefusion RSV F Glycoprotein · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.